Answers are grounded in this paper and cite their sources.
Synthesis of bimetallic catalyst reveals 90.3% tetracycline removal in wastewater, indicating enhanced degradation performance.
The increasing levels of pollutants have led to a growing demand for wastewater treatment technologies. Fenton-like processes that require no external energy input are particularly promising. In this study, a dual-metal Cu, Mn-doped LaFeO3 perovskite oxide catalyst (LaFeCuMn) using a simple citrate-assisted sol-gel method has been successfully synthesized and demonstrated for tetracycline (TC) degradation. LaFeCuMn achieves a 90.3% removal rate of high-concentration TC of 40 ppm, within 30 minutes, which is six times higher than that of LaFeO3 and superior to single-metal doped samples. The enhanced TC degradation is attributed to dual doping, which optimizes the presence of oxygen vacancies, promoting H2O2 adsorption and subsequently allowing the O-O bond from H2O2 to dissociate into an OH radical. The electron transfer among Fe, Cu, and Mn promotes the regeneration of Fe2+, Cu+, and Mn2+ active sites. The TC degradation performance of LaFeCuMn outperforms that of most reported TC degradation in the literature, confirming its promise for practical applications.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: